(5R)-3-[5-(1,2-oxazol-5-yl)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2,5,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidine-5-carboxamide

C19H17N5O4 — CID 58746277

IUPAC(5R)-3-[5-(1,2-oxazol-5-yl)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2,5,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidine-5-carboxamide
SMILESNC(=O)[C@H]1CN(c2ccc3c(c2)CCCc2c-3n[nH]c2-c2ccno2)C(=O)O1
InChIInChI=1S/C19H17N5O4/c20-18(25)15-9-24(19(26)27-15)11-4-5-12-10(8-11)2-1-3-13-16(12)22-23-17(13)14-6-7-21-28-14/h4-8,15H,1-3,9H2,(H2,20,25)(H,22,23)/t15-/m1/s1
InChIKeyQUKPQZYBCCEYRO-OAHLLOKOSA-N
MW379.38 g/mol
LogP2.03
Rot. Bonds3

About (5R)-3-[5-(1,2-oxazol-5-yl)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2,5,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidine-5-carboxamide

(5R)-3-[5-(1,2-oxazol-5-yl)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2,5,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidine-5-carboxamide (PubChem CID 58746277) has the molecular formula C19H17N5O4 and a molecular weight of 379.38 g/mol. Its IUPAC name is (5R)-3-[5-(1,2-oxazol-5-yl)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2,5,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidine-5-carboxamide.

Molecular Properties

Compound Name(5R)-3-[5-(1,2-oxazol-5-yl)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2,5,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidine-5-carboxamide
PubChem CID58746277
Molecular FormulaC19H17N5O4
Molecular Weight379.38 g/mol
Exact Mass379.13
IUPAC Name(5R)-3-[5-(1,2-oxazol-5-yl)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2,5,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidine-5-carboxamide
SMILESNC(=O)[C@H]1CN(c2ccc3c(c2)CCCc2c-3n[nH]c2-c2ccno2)C(=O)O1
InChIInChI=1S/C19H17N5O4/c20-18(25)15-9-24(19(26)27-15)11-4-5-12-10(8-11)2-1-3-13-16(12)22-23-17(13)14-6-7-21-28-14/h4-8,15H,1-3,9H2,(H2,20,25)(H,22,23)/t15-/m1/s1
InChIKeyQUKPQZYBCCEYRO-OAHLLOKOSA-N
XLogP2.03
TPSA127.34 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds3
Heavy Atoms28
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500379.38
LogP ≤ 52.03
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze (5R)-3-[5-(1,2-oxazol-5-yl)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2,5,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidine-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[[(5S)-3-[5-(4-hydroxyfuran-3-yl)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2(6),4,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
CID 10002335
N-[[(5S)-3-[5-(4-fluorofuran-3-yl)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2(6),4,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
CID 10025361
(5R)-3-(3-ethyl-4,5-dihydro-2H-[1]benzoxepino[5,4-c]pyrazol-8-yl)-2-oxo-1,3-oxazolidine-5-carboxamide
CID 58746282
(5R)-3-[14-fluoro-5-(methylamino)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2(6),4,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidine-5-carboxamide
CID 58746357
N-[[(5S)-2-oxo-3-[5-[2-(trifluoromethoxy)phenyl]-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2(6),4,11,13-pentaen-12-yl]-1,3-oxazolidin-5-yl]methyl]acetamide
CID 10481092
N-[[(5S)-2-oxo-3-[5-[4-(trifluoromethoxy)furan-3-yl]-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2(6),4,11,13-pentaen-12-yl]-1,3-oxazolidin-5-yl]methyl]acetamide
CID 10458281
N-[[(5S)-2-oxo-3-[5-(2-oxo-1H-pyridin-4-yl)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2(6),4,11,13-pentaen-12-yl]-1,3-oxazolidin-5-yl]methyl]acetamide
CID 10002973
N-[[(5S)-2-oxo-3-(5-thiophen-3-yl-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2(6),4,11,13-pentaen-12-yl)-1,3-oxazolidin-5-yl]methyl]acetamide
CID 10477334
azane;(5R)-3-(1-cyclobutyl-2-oxo-3H-indol-5-yl)-2-oxo-1,3-oxazolidine-5-carboxamide
CID 160735007
N-[[(5S)-3-[5-(2-fluoro-4-pyridinyl)-3-oxa-4-azatricyclo[8.4.0.02,6]tetradeca-1(10),2(6),4,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
CID 10365728
N-[[(5S)-3-[5-(3-methoxy-4-pyridinyl)-3-oxa-4-azatricyclo[8.4.0.02,6]tetradeca-1(10),2(6),4,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
CID 10026667
3-[3-fluoro-4-(1,4-oxazepan-4-yl)phenyl]-2-oxo-1,3-oxazolidine-5-carboxamide
CID 69022376

Frequently Asked Questions

What is the IUPAC name of (5R)-3-[5-(1,2-oxazol-5-yl)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2,5,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidine-5-carboxamide?
The IUPAC name of (5R)-3-[5-(1,2-oxazol-5-yl)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2,5,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidine-5-carboxamide (CID 58746277) is (5R)-3-[5-(1,2-oxazol-5-yl)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2,5,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidine-5-carboxamide.
What is the SMILES notation for (5R)-3-[5-(1,2-oxazol-5-yl)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2,5,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidine-5-carboxamide?
The canonical SMILES for (5R)-3-[5-(1,2-oxazol-5-yl)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2,5,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidine-5-carboxamide is NC(=O)[C@H]1CN(c2ccc3c(c2)CCCc2c-3n[nH]c2-c2ccno2)C(=O)O1.
What is the InChIKey of (5R)-3-[5-(1,2-oxazol-5-yl)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2,5,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidine-5-carboxamide?
The InChIKey is QUKPQZYBCCEYRO-OAHLLOKOSA-N. The full InChI is InChI=1S/C19H17N5O4/c20-18(25)15-9-24(19(26)27-15)11-4-5-12-10(8-11)2-1-3-13-16(12)22-23-17(13)14-6-7-21-28-14/h4-8,15H,1-3,9H2,(H2,20,25)(H,22,23)/t15-/m1/s1.
What are the key properties of (5R)-3-[5-(1,2-oxazol-5-yl)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2,5,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidine-5-carboxamide?
(5R)-3-[5-(1,2-oxazol-5-yl)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2,5,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidine-5-carboxamide has a molecular weight of 379.38 g/mol, XLogP of 2.03, 3 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (5R)-3-[5-(1,2-oxazol-5-yl)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2,5,11,13-pentaen-12-yl]-2-oxo-1,3-oxazolidine-5-carboxamide is sourced from PubChem (CID 58746277), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).